" /> Megalencephaly-capillary malformation-polymicrogyria syndrome - CISMeF





Preferred Label : Megalencephaly-capillary malformation-polymicrogyria syndrome;

Symbol : MCAP;

CISMeF acronym : MCAP;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : Macrocephaly-capillary malformation; Megalencephaly-capillary malformation syndrome; MCMTC; Megalencephaly-cutis marmorata telangiectatica congenita; Macrocephaly-cutis marmorata telangiectatica congenita; MCM;

Description : Megalencephaly-capillary malformation-polymicrogyria syndrome (MCAP) is characterized by a spectrum of anomalies including primary megalencephaly, prenatal overgrowth, brain and body asymmetry, cutaneous vascular malformations, digital anomalies consisting of syndactyly with or without postaxial polydactyly, connective tissue dysplasia involving the skin, subcutaneous tissue, and joints, and cortical brain malformations, most distinctively polymicrogyria (summary by Mirzaa et al., 2012). This disorder is also known as the macrocephaly-capillary malformation (MCM) syndrome (Conway et al., 2007). Mirzaa et al. (2012) suggested use of the term MCAP rather than MCM to reflect the very large brain size, rather than simply large head size, that characterizes this syndrome, and the importance and high frequency of perisylvian polymicrogyria.;

Inheritance : Somatic mutation;

Molecular basis : Caused by somatic mutation in the phosphatidylinositol 3-kinase, catalytic, alpha polypeptide gene (PIK3CA, 171834.0003);

Neoplasia : Increased risk of meningioma; Increased risk of Wilms tumor; Increased risk of leukemia;

Prefixed ID : #602501;

Details


You can consult :


Nous contacter.
18/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.